Evidence map›Paper›PMID 42428842›Full record

ArticleACS omega2026

Selection of Novel DNA Aptamers against HPV16 Biomarker, E6: An

Bonke Phathekile, Darius Riziki Martin, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe, Martin Opiyo Onani, Mervin Meyer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bonke PhathekileOrganometallics and Nanomaterials, Department of Chemical Sciences, University of the Western Cape, Bellville, Cape Town 7535, South Africa.ORCID https://orcid.org/0000-0002-2097-0958
Darius Riziki MartinDepartment of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.ORCID https://orcid.org/0000-0001-8673-1581
Nicole Remaliah Samantha SibuyiDepartment of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.ORCID https://orcid.org/0000-0001-7175-5388
Abram Madimabe MadieheDepartment of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.
Martin Opiyo OnaniOrganometallics and Nanomaterials, Department of Chemical Sciences, University of the Western Cape, Bellville, Cape Town 7535, South Africa.ORCID https://orcid.org/0000-0002-4735-3669
Mervin MeyerDepartment of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HPV16 E6 oncoprotein is a critical driver of cervical cancer, necessitating high-specificity diagnostic and therapeutic agents. This study presents an

Identifiers

PMID42428842
PMCPMC13347393

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.